Ibuprofen Dr.Max (Ibuprofen)

Ibuprofen blocks the activity of cyclooxygenase enzymes (COX‑1 and COX‑2), which are needed to produce prostaglandins. Prostaglandins promote pain, swelling and fever, so their reduction leads to decreased inflammation, analgesia and antipyretic effects at the site where the product is applied.

The appropriate amount of Ibuprofen Dr.Max is determined by the prescribing clinician based on the patient’s age, condition and response. Patients should follow the specific instructions on the label or those given by their healthcare provider and should not exceed the recommended application frequency.

Safety of topical ibuprofen in pregnancy or while breastfeeding has not been fully established. Women who are pregnant, planning pregnancy, or nursing should consult their physician before using the product to weigh potential benefits against any possible risks.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Both ibuprofen and diclofenac belong to the NSAID class and share similar mechanisms of COX inhibition. Ibuprofen is often preferred for its shorter half‑life and lower cardiovascular risk profile, while diclofenac may be chosen for its potency in certain chronic inflammatory conditions. The choice depends on clinical judgment and patient tolerance.

Store Ibuprofen Dr.Max at room temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture, direct sunlight and extreme temperatures to maintain stability and effectiveness.

Apply a thin layer of the gel or cream to the affected skin area, gently massaging it in until fully absorbed. Use the amount and frequency recommended on the label or by a healthcare professional, and wash hands after application to avoid accidental contact with eyes or mucous membranes.

Serious adverse reactions, although rare, include severe allergic responses such as anaphylaxis, Stevens‑Johnson syndrome, toxic epidermal necrolysis, and systemic toxicity leading to gastrointestinal bleeding or cardiovascular events. Immediate medical attention is required if signs of a severe reaction appear.

Individuals with a known allergy to ibuprofen, other NSAIDs, or any component of the formulation should avoid the product. It is also contraindicated for people with active gastrointestinal ulcers, severe heart failure, or those who are currently taking anticoagulants or other NSAIDs without medical supervision.